China Biotech Services Holdings Limited (8037.HK)

HKD 0.4

(0.0%)

Net Debt Summary of China Biotech Services Holdings Limited

  • China Biotech Services Holdings Limited's latest annual net debt in 2023 was -106.5 Million HKD , down -869.42% from previous year.
  • China Biotech Services Holdings Limited's latest quarterly net debt in 2024 Q1 was 121.85 Million HKD , up 214.41% from previous quarter.
  • China Biotech Services Holdings Limited reported annual net debt of -10.98 Million HKD in 2022, up 86.82% from previous year.
  • China Biotech Services Holdings Limited reported annual net debt of -83.38 Million HKD in 2021, up 70.03% from previous year.
  • China Biotech Services Holdings Limited reported quarterly net debt of 121.85 Million HKD for 2024 Q2, up 9.66% from previous quarter.
  • China Biotech Services Holdings Limited reported quarterly net debt of 245.39 Million HKD for 2023 Q3, up 239.04% from previous quarter.

Annual Net Debt Chart of China Biotech Services Holdings Limited (2023 - 2005)

Historical Annual Net Debt of China Biotech Services Holdings Limited (2023 - 2005)

Year Net Debt Net Debt Growth
2023 -106.5 Million HKD -869.42%
2022 -10.98 Million HKD 86.82%
2021 -83.38 Million HKD 70.03%
2020 -278.19 Million HKD -8299.73%
2019 -3.31 Million HKD 97.79%
2018 -149.6 Million HKD -259.31%
2017 -41.63 Million HKD -227.32%
2016 -12.72 Million HKD 82.65%
2015 -73.31 Million HKD -263.87%
2014 -20.14 Million HKD -174.37%
2013 27.09 Million HKD 204.01%
2012 -26.04 Million HKD -812.4%
2011 -2.85 Million HKD 95.94%
2010 -70.31 Million HKD -430.93%
2009 21.24 Million HKD -17.55%
2008 25.77 Million HKD 63.89%
2007 15.72 Million HKD 168.82%
2006 -22.85 Million HKD -10.34%
2005 -20.71 Million HKD 0.0%

Peer Net Debt Comparison of China Biotech Services Holdings Limited

Name Net Debt Net Debt Difference
Life Healthcare Group Limited 5.23 Million HKD 2134.773%